Methocarbamol suspension for the treatment of rhabdomyolysis in equines.

The research centers on the use of a methocarbamol suspension for treating rhabdomyolysis in horses. Rhabdomyolysis is a condition that typically results from heavy exercise or some pathological condition, and methocarbamol is a muscle relaxant that has been used to manage related symptoms.

Overview of Rhabdomyolysis

• Rhabdomyolysis is a condition frequently seen in horses, triggered by intense physical exertion or a pathologic myopathy, which is a disease of the muscle.
• Commonly referred to as ‘Tying-up‘, Rhabdomyolysis in horses results in muscle stiffness, pain, and potentially damage to muscle tissue due to the sudden release of muscle cell contents into the bloodstream.

Role of Methocarbamol Treatment

• Methocarbamol is currently used as a standard treatment for symptoms associated with Rhabdomyolysis in horses. It functions as a muscle relaxant that eases muscle stiffness and pain brought about by the ailment.
• Despite being commercially available as an injectable solution, methocarbamol is not commonly marketed in the form of an oral suspension, which might provide more convenience, particularly in long-term management and cases where injections prove challenging.

The Introduction of Methocarbamol Suspension

• This research article expands on the practical implementation of a methocarbamol oral suspension that was specifically created for a veterinarian by a compounding pharmacist.
• The use of this custom-compounded oral suspension opens new avenues for the specific treatment of Rhabdomyolysis, enabling easier administration and potentially improving patient compliance.